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A B S T R A C T   
Objectives: This study aimed to identify, describe and analyze priority areas for COVID-19 testing combining 
participatory surveillance and traditional surveillance. 
Design: It was carried out a descriptive transversal study in the city of Caruaru, Pernambuco state, Brazil, within 
the period of 20/02/2020 to 05/05/2020. Data included all official reports for influenza-like illness notified by 
the municipality health department and the self-reports collected through the participatory surveillance platform 
Brasil Sem Corona. 
Methods: We used linear regression and loess regression to verify a correlation between Participatory Surveillance 
(PS) and Traditional Surveillance (TS). Also a spatial scanning approach was deployed in order to identify risk 
clusters for COVID-19. 
Results: In Caruaru, the PS had 861 active users, presenting an average of 1.2 reports per user per week. The 
platform Brasil Sem Corona started on March 20th and since then, has been officially used by the Caruaru health 
authority to improve the quality of information from the traditional surveillance system. Regarding the respi-
ratory syndrome cases from TS, 1588 individuals were positive for this clinical outcome. The spatial scanning 
analysis detected 18 clusters and 6 of them presented statistical significance (p-value < 0.1). Clusters 3 and 4 
presented an overlapping area that was chosen by the local authority to deploy the COVID-19 serology, where 50 
individuals were tested. From there, 32 % (n = 16) presented reagent results for antibodies related to COVID-19. 
Conclusion: Participatory surveillance is an effective epidemiological method to complement the traditional 
surveillance system in response to the COVID-19 pandemic by adding real-time spatial data to detect priority 
areas for COVID-19 testing.   
1. Introduction 
Participatory surveillance has shown promising results from its 
conception to its application in several public health events [1–6]. The 
use of a collaborative information pathway provides a rapid way for the 
data collection on symptomatic individuals in the territory, to comple-
ment traditional health surveillance systems [7,8]. In Brazil, this 
methodology has been used at the national level since 2014 during mass 
gatherings events since they have great importance for monitoring 
public health emergencies [9,10]. With the occurrence of the COVID-19 
pandemic, and the limitation of the main non-pharmaceutical 
interventions for epidemic control - in this case, testing and social 
isolation - added to the challenge of existing underreporting of cases and 
delay of notifications, there is a demand on alternative sources of up to 
date information to complement the current system for disease sur-
veillance. Several studies [11–14] have demonstrated the benefits of 
participatory surveillance in coping with COVID-19, reinforcing the 
opportunity to modernize the way health surveillance has been carried 
out. Additionally, spatial scanning techniques have been used to un-
derstand syndromic scenarios, investigate outbreaks, and analyze 
epidemiological risk, constituting relevant tools for health management 
[15–18]. While there are limitations in the quality of traditional health 
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systems, the data generated by participatory surveillance reveals an 
interesting application combining traditional techniques to clarify 
epidemiological risks that demand urgency in decision-making. More-
over, with the limitations of testing available, the identification of pri-
ority areas for intervention is an important activity in the early response 
to public health emergencies. This study aimed to describe and analyze 
priority areas for COVID-19 testing combining data from participatory 
surveillance and traditional surveillance for respiratory syndromes. 
2. Methods 
The study’s method is a descriptive transversal, performed in the city 
of Caruaru, Pernambuco state, within the period of 02/20/2020 to 05/ 
05/2020. Data included all official reports for influenza-like illness 
notified by municipality health department and the self-reports 
collected through the participatory surveillance platform Brasil Sem 
Corona [19]. 
To volunteer for the Brasil Sem Corona participatory surveillance 
platform, the individual should download an app called Colab. Through 
that, the volunteer has the option to agree with its terms of use that 
describe the purpose of this platform and ethical aspects, including the 
use of data for scientific studies that will help local public health au-
thorities to improve the understanding of the epidemiological setting. 
After accepting the terms and conditions, participants can fill out a self- 
report questionnaire on symptoms and exposure in order to actively 
inform their health status. This questionnaire is based in a syndromic 
approach, including symptoms that are related with respiratory syn-
drome mixing up protocols used for participatory surveillance [9,10]. 
Moreover, questions that could help to understand the severity of 
symptoms, such as if user sought a health facility or if it has elderly 
people as household members. 
Daily reports are permitted, and a participant can report a maximum 
of two reports a day. Each time a participant completes and submits a 
report, it provides the respective latitude and longitude, which are 
anonymized in the server within a radius of 2 km. Personal identification 
is also anonymized, and participants can drop out their enrollment in the 
platform at any time, and the data is completely deleted from the 
servers, following national privacy laws. 
Data from traditional disease surveillance system was accessed by 
the epidemiological bulletins, publicly available at local government 
communication channels. 
To verify a correlation between participatory surveillance (PS) and 
traditional surveillance (TS), it was carried out a linear regression [20] 
extracting summary of fit and parameter estimates: 
γ = α + βχ + εi.
A local polynomial regression (LOESS) [21] was also performed to 
generalize a moving average to generate a scatterplot smoothing among 






where d is the distance of data point from the point on the curve being 
fitted, scaled to lie in the range from 0 to 1. 
On the spatial scanning method, it was performed a purely spatial 
analysis scanning for clusters with high rates using Bernoulli model 
assuming that in the studied area there are cases and non-cases repre-
sented by a dummy variable, acting as a spatial case (respiratory syn-
drome cases)/control (users that responded no symptoms) approach. It 
was decided not use temporal parameters for the SatScan analysis due to 
case-report delay from TS as well as the latency of 14 days that could be 
possible on COVID-19 cases. 
The likelihood function for the Bernoulli [22] model is expressed as 
L(Z, p, q) = pnZ(1 − p)μ(Z)−nZqnG−nZ(1 − q)(μ(G)− μ(Z) )−(nG−nZ).
In order to detect the zone that is most likely to be a cluster, it was 
found the zone Ž that maximized the likelihood function, where Ž is the 
maximum likelihood estimator of the parameter Z. To achieve this, it 
needs to have two-stage actions. First, maximize the likelihood function 
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Second, to find the solution Ẑ = {Z : L(Z) ≥ L(Z’)∀Z’ ∈ Z }
The most likely cluster is of interest in itself,
but it is important also to have a statistical inference. Let  








the likelihood ratio, λ, can be written as 
λ =
supZ∈Z, p>qL(Z, p, q)





In addition, the SatScan runs a Monte Carlo simulation based on 
pseudo-random number generators. This allows to obtain the p-value for 
hypothesis testing, comparing the rank of the maximum likelihood from 
the real data set with the maximum likelihood from the random data 
sets. 
In this case of spatial scanning clusters, statistical significance was 
defined as p-value < 0.1, bringing not only the clusters with a confi-
dence interval of 95 % and a maximum error of 5 % but also considering 
a credible interval of 90 % and a maximum error of 10 %. 
For the clusters that presented statistical significance [23], an 
overlaying in a geographic information system was done using QGIS 
3.12 [24]. This map was used by the local authority to choose the area to 
deploy 50 serology tests for COVID-19. Other 50 tests were deployed in 
areas outside those clusters. For data wrangling, data tidying, and data 
visualization, an R language framework was used (Exploratory.io) [25]. 
For spatial scanning analysis, SatScan v9.6 [26] was adopted. 
The study had an exemption from the oversight body (Caruaru 
Health Department and Brasil Sem Corona scientific committee) since 
only public domain data available from secondary sources were used. 
3. Results 
In Caruaru, the PS had 861 active users, presenting an average of 1.2 
reports per user per week. The median age of users was 36 (mean 36.96; 
standard deviation 9.41; minimum age of 14 years old and maximum 
age of 60 years old). 
The platform Brasil Sem Corona started on March 20th 2020 and 
since then, has been officially used by the Caruaru health authority to 
improve the quality of information from the traditional surveillance 
system. Massive marketing campaigns using the official social media 
channels for the local government were used to advertise and engage 
new users. 
Regarding the respiratory syndrome cases from TS, 1588 individuals 
were positive for this clinical outcome. For the PS, it was considered 798 
users that reported no symptoms in the period of study. Figs. 1 and 2 
shows the temporal and spatial distribution of cases (TS) and controls 
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Fig. 1. Temporal distribution of reports from traditional surveillance and participatory surveillance.  
Fig. 2. Spatial distribution of cases and controls over the city of Caruaru in the period of study.  
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(PS). 
When performed the signal (PS or TS) over time, it was found a linear 
correlation among these outputs and predictors where PS showed a 
correlation of 0.72 (R squared 0.52) and a coefficient of 1.17 (p-value <
0.001). When verified the results for TS, correlation showed an output of 
0.6198 (R squared 0.38) and a coefficient of 1.13 (p-value < 0.001). 
Regarding the LOESS (Fig. 3), PS has shown an equivalent number of 
parameters of 4.37, with a residual standard error of 17.00 and a trace of 
smoother matrix of 4.78. Finally, TS has shown as an equivalent number 
of parameters 4.62, residual standard error of 18.01, and a trace of 
smoother matrix of 5.07. 
The spatial scanning analysis has detected 18 clusters and 6 of them 
have presented statistical significance (p-value < 0.1) (Table 1). Clusters 
3 and 4 presented an overlapping and this area was chosen by the local 
authority to deploy the COVID-19 serology, where 50 individuals were 
tested (Fig. 4). From there, 32 % (n = 16) presented reagent results for 
antibodies related to COVID-19, where the spatial scanning showed a hit 
rate between 84 % and 94 %. Another group of 50 individuals were 
tested outside identified clusters and from there, only 4 % (n = 2) were 
positive for COVID-19 serology. 
4. Discussion 
The combination of TS and PS showed a relevant potential in the 
improvements of disease surveillance in the studied region, presenting 6 
risk clusters that supported the decision of health managers. City areas 
that do not have health facilities can take advantage of the use of PS in 
order to cover blind spots for the TS, increasing the sensitivity and 
specificity of the official disease surveillance system. 
There was a strong correlation between the participation of in-
dividuals in the PS strategy over time, whereas there was a moderate 
association in the same period with the increase in notifications related 
to influenza syndrome from TS. 
Regarding spatial scanning, the use of clusters to target priority re-
gions for testing was of relevant importance in the adequacy and 
rationalization of the use of diagnostic resources, which are sometimes 
scarce in different contexts. The finding of 32 % people reagent for the 
COVID-19 antibody in areas that the analysis showed a variation be-
tween 34 % and 38 % demonstrates an excellent result for the method to 
be replicated not only in this city, but also in other places that need tools 
to prioritization of tests. The remaining clusters that did not overlap but 
were statistically significant will be implemented in the coming weeks. 
The challenge of coping with COVID-19 is even greater in settings 
Fig. 3. Time series distribution with LOESS regression for each source.  
Table 1 
Summary of clusters including relative risk, log likelihood ratio and p-value.  
Cluster Relative risk Log likelihood ratio P-value 
1 1.54 44.504679 0.001 
2 1.53 26.568310 0.001 
3 1.34 13.654698 0.003 
4 1.38 12.143518 0.013 
5 1.45 11.350351 0.021 
6 1.46 9.770844 0.094 
7 1.51 8.619205 0.274 
8 1.37 8.025044 0.404 
9 1.31 7.421699 0.544 
10 1.51 7.382095 0.616 
11 1.51 6.970157 0.728 
12 1.51 6.970157 0.728 
13 1.51 6.558434 0.848 
14 1.35 6.492181 0.854 
15 1.51 5.735634 0.975 
16 1.29 5.413135 0.982 
17 1.51 5.324557 0.994 
18 1.51 5.324557 0.994  
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where there is a lack of access for testing, low schooling of the popu-
lation, and minor investment in health policies. In addition, there are a 
large number of cases that are not registered due to the small number of 
symptoms [27] or by complete absence [28] of any symptoms that may 
guide accurate health care, at the right time and in the right place. 
Brazil is one of the countries that have the lowest number of tests 
among those that have the highest number of confirmed cases for 
COVID-19, and one of the epicenters is the state of Pernambuco, where 
the number of cases can be up to 10 times greater than those officially 
presented in epidemiological reports [29]. The study region became 
known as one of the main areas affected by the Zika Virus syndrome in 
2015 and 2016 [30], where there is a population that is affected by 
several problems such as measles, leprosy, and other diseases overcome 
elsewhere of the world. This increases the need for rapid response during 
the COVID-19 pandemic, since the health system is already overloaded 
with basal demands. 
Even though most of the documented cases of COVID-19, in studies 
carried out in China, are in the age group between 30–79 years old [31], 
the fact we can observe in the PS a more prevalent age group of 36 is a 
relative trend on the use of digital mobile apps for a younger adults. This 
trend followed previous studies made in Brazil using participatory sur-
veillance during mass gatherings [9,10]. In addition, for the present 
study another relevant finding is that the detected clusters were present 
in low-income areas that corroborate with other finds in Brazil [32]. 
In a study carried out by the Imperial College of London comparing 
the evolution of COVID-19 in 54 countries on several continents, it 
showed that Brazil is the country most threatened to be one of the main 
epicenters of the disease in the world, mainly due to the great possibility 
of spreading the disease with an R0 greater than 2 and an increasing 
number of deaths [33]. Knowledge of risk areas is essential for appro-
priate non-pharmacological interventions [34], as well as for the defi-
nition of priorities regarding medical care, for example. The best time to 
start treatment is another big challenge because as the disease has a 
rapid and almost silent evolution, knowing where the probable cases are 
can save lives, expand the possibility of differential diagnosis and favor 
an effective treatment. 
The use of alternative methods as participatory surveillance showed 
a relevant role by taking advantage on the insertion at community 
levels, generating real-time spatial information not only for self-reported 
symptoms individuals but also for participants that informed to have no 
symptoms. Although the presented approach demands other sorts of 
validation and diagnostic methods (PCR) and it also needs to be carried 
out in different cities to address potential biases, our application shows 
an alternative to rapid mass screening in areas to prioritize tests and 
supporting local public health authorities to implement public policies 
based in evidence. 
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